A role for presynaptic mechanisms in the actions of nomifensine and haloperidol

Neuroscience

Volumn 118, Issue 3, 2003, Pages 819-829

  Garris, P A ^a   Budygin, E A ^b   Phillips, P E M ^b   Venton, B J ^b   Robinson, D L ^b   Bergstrom, B P ^a   Rebec, G V ^c   Wightman, R M ^b  

^a ILLINOIS STATE UNIVERSITY   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Autoreceptor; Dopamine; Haloperidol; Nomifensine; Transporter; Voltammetry

Indexed keywords

CENTRAL STIMULANT AGENT; DOPAMINE AUTORECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; HALOPERIDOL; NEUROLEPTIC AGENT; NOMIFENSINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH RECORDING; CATALEPSY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG MECHANISM; ELECTROSTIMULATION; MALE; MOBILIZATION; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PUTAMEN; RAT;

EID: 0242501519     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00005-8     Document Type: Article

References (69)

1. Allen C., Peters J.L., Sesack S.R., Michael A.C. Microelectrodes closely approach intact nerve terminals in vivo, while larger devices do not: a study using electrochemistry and electron microscopy. O'Connor W.T., Lowry J.P., O'Connor J.J., O'Neill R.D. Monitoring molecules in neuroscience: proceedings of the 9th International Conference In Vivo Methods. 2001;89-90 University College, Dublin, Ireland.
2. Artigas F., Celada P., Laruelle M., Adell A. How does pindolol improve antidepressant action? Trends Pharmacol Sci. 22:2001;224-228.
3. Badiani A., Oates M.M., Day H.E., Watson S.J., Akil H., Robinson T.E. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression modulation by environmental novelty . J Neurosci. 18:1998;10579-10593.
4. Bath B.D., Michael D.J., Trafton B.J., Joseph J.D., Runnels P.L., Wightman R.M. Subsecond adsorption and desorption of dopamine at carbon-fiber microelectrodes. Anal Chem. 72:2000;5994-6002.
5. Baur J.E., Kristensen E.W., May L.J., Wiedemann D.J., Wightman R.M. Fast-scan voltammetry of biogenic amines. Anal Chem. 60:1988;1268-1272.
6. Benveniste H., Diemer N.H. Cellular reactions to implantation of a microdialysis tube in the rat hippocampus. Acta Neuropathol (Berl). 74:1987;234-238.
7. Bjorklund A., Lindvall O. Dopamine-containing systems in the CNS. Bjorklund A., Hokfelt T. Handbook of chemical neuroanatomy. 1984;55-122 Elsevier, New York.
8. Boja J.W., Kuhar M.J. [3H]cocaine binding and inhibition of [3H]dopamine uptake is similar in both the rat striatum and nucleus accumbens. Eur J Pharmacol. 173:1989;215-217.
9. Budygin E.A., Kilpatrick M.R., Gainetdinov R.R., Wightman R.M. Correlation between behavior and extracellular dopamine levels in rat striatum comparison of microdialysis and fast-scan cyclic voltammetry . Neurosci Lett. 281:2000;9-12.
10. Bunney B.S., Chiodo L.A., Grace A.A. Midbrain dopamine system electrophysiological functioning a review and new hypothesis . Synapse. 9:1991;79-94.
11. Cahill P.S., Walker Q.D., Finnegan J.M., Mickelson G.E., Travis E.R., Wightman R.M. Microelectrodes for the measurement of catecholamines in biological systems. Anal Chem. 68:1996;3180-3186.
12. Chiodo L.A., Bunney B.S. Typical and atypical neuroleptics differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons . J Neurosci. 3:1983;1607-1619.
13. Clapp-Lilly K.L., Roberts R.C., Duffy L.K., Irons K.P., Hu Y., Drew K.L. An ultrastructural analysis of tissue surrounding a microdialysis probe. J Neurosci Methods. 90:1999;129-142.
14. Costall B., Kelly D.M., Naylor R.J. Nomifensine a potent dopaminergic agonist of antiparkinson potential . Psychopharmacologia. 41:1975;153-164.
15. Costall B., Naylor R.J., Olley J.E. Stereotypic and anticataleptic activities of amphetamine after intracerebral injections. Eur J Pharmacol. 18:1972;83-94.
16. Davidson C., Ellinwood E.H., Douglas S.B., Lee T.H. Effect of cocaine, nomifensine, GBR 12909 and WIN 35428 on carbon fiber microelectrode sensitivity for voltammetric recording of dopamine. J Neurosci Methods. 101:2000;75-83.
17. Di Chiara G., Imperato A. Rapid tolerance to neuroleptic-induced stimulation of dopamine release in freely moving rats. J Pharmacol Exp Ther. 235:1985;487-494.
18. Engberg G., Elverfors A., Jonason J., Nissbrandt H. Inhibition of dopamine re-uptake significance for nigral dopamine neuron activity . Synapse. 25:1997;215-226.
19. Fog R. On stereotypy and catalepsy studies on the effect of amphetamines and neuroleptics in rats . Acta Neurol Scand Suppl. 50:1972;3-66.
20. Garris P.A., Christensen J.R., Rebec G.V., Wightman R.M. Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. J Neurochem. 68:1997;152-161.
21. Garris P.A., Kilpatrick M., Bunin M.A., Michael D., Walker Q.D., Wightman R.M. Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature. 398:1999;67-69.
22. Gianutsos G., Morrow G., Light S., Sweeney M.J. Dopaminergic properties of nomifensine. Pharmacol Biochem Behav. 17:1982;951-954.
23. Heikkila R.E., Shapiro B.S., Duvoisin R.C. The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats. Brain Res. 211:1981;285-292.
24. Helmeste D.M., Seeman P. [3H]haloperidol binding to more than one site in rat brain striatum. Biochem Pharmacol. 32:1983;741-744.
25. Hoffman A.F., Zahniser N.R., Lupica C.R., Gerhardt G.A. Voltage-dependency of the dopamine transporter in the rat substantia nigra. Neurosci Lett. 260:1999;105-108.
26. Hurd Y.L., Ungerstedt U. In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur J Pharmacol. 166:1989;251-260.
27. Imperato A., Di Chiara G. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci. 5:1985;297-306.
28. Jones S.R., Garris P.A., Kilts C.D., Wightman R.M. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J Neurochem. 64:1995;2581-2589.
29. Joseph M.H. Can voltammetric electrodes measure brain extracellular dopamine in the behaving animal? Commentary on Blaha and Phillips', 'A critical assessment of electrochemical procedures applied to the measurement of dopamine and its metabolites during drug-induced and species-typical behaviours'. Behav Pharmacol. 7:1996;709-713.
30. Julien R.M. A primer of drug action. 1985;W. H. Freeman, New York.
31. Kawagoe K.T., Garris P.A., Wiedemann D.J., Wightman R.M. Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum. Neuroscience. 51:1992;55-64.
32. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:1975;507-522.
33. Kilpatrick M.R., Rooney M.B., Michael D.J., Wightman R.M. Extracellular dopamine dynamics in rat caudate-putamen during experimenter-delivered and intracranial self-stimulation. Neuroscience. 96:2000;697-706.
34. Kiyatkin E.A., Kiyatkin D.E., Rebec G.V. Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats. Neuroscience. 98:2000;729-741.
35. Kuczenski R., Segal D.S., Aizenstein M.L. Amphetamine, cocaine, and fencamfamine relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics . J Neurosci. 11:1991;2703-2712.
36. Lu Y., Peters J.L., Michael A.C. Direct comparison of the response of voltammetry and microdialysis to electrically evoked release of striatal dopamine. J Neurochem. 70:1998;584-593.
37. Marsden C.A., Joseph M.H., Kruk Z.L., Maidment N.T., O'Neill R.D., Schenk J.O., Stamford J.A. In vivo voltammetry present electrodes and methods . Neuroscience. 25:1988;389-400.
38. May L.J., Kuhr W.G., Wightman R.M. Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J Neurochem. 51:1988;1060-1069.
39. Mercuri N.B., Stratta F., Calabresi P., Bernardi G. Nomifensine but not amantadine increases dopamine-induced responses on rat substantia nigra zona compacta neurons. Neurosci Lett. 131:1991;145-148.
40. Mereu G., Lilliu V., Vargiu P., Muntoni A.L., Diana M., Gessa G.L. Depolarization inactivation of dopamine neurons an artifact? J Neurosci. 15:1995;1144-1149.
41. Michael D.J., Joseph J.D., Kilpatrick M.R., Travis E.R., Wightman R.M. Improving data acquisition for fast-scan cyclic voltammetry. Anal Chem. 71:1999;3941-3947.
42. Moghaddam B., Bunney B.S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat an in vivo microdialysis study . J Neurochem. 54:1990;1755-1760.
43. Moore R.Y., Card J.P. Noradrenaline-containing neurons systems. Bjorklund A., Hokfelt T. Classical transmitters in the CNS, part I. 1984;123-156 Elsevier, New York.
44. Murray A.M., Waddington J.L. New putative selective agonists at the D-1 dopamine receptor behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243 . Pharmacol Biochem Behav. 35:1990;105-110.
45. Nakachi N., Kiuchi Y., Inagaki M., Inazu M., Yamazaki Y., Oguchi K. Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats. Eur J Pharmacol. 281:1995;195-203.
46. Nirenberg M.J., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci. 16:1996;436-447.
47. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse. 6:1990;106-112.
48. Opacka-Juffry J., Ahier R.G., Cremer J.E. Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anaesthesia. Synapse. 7:1991;169-171.
49. Osborne P.G., O'Connor W.T., Beck O., Ungerstedt U. Acute versus chronic haloperidol relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release . Brain Res. 634:1994;20-30.
50. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, New York.
51. Phillips P.E.M., Budygin E.A., Garris P.A., Robinson D.L., Wightman R.M. The presynaptic effect of haloperidol delays catalepsy implications for its neuroleptic action . Neurosci Abstr. 27:2001;2328.
52. Rebec G.V., Centore J.M., White L.K., Alloway K.D. Ascorbic acid and the behavioral response to haloperidol implications for the action of antipsychotic drugs . Science. 227:1985;438-440.
53. Roberts D.C., Zis A.P., Fibiger H.C. Ascending catecholamine pathways and amphetamine-induced locomotor activity importance of dopamine and apparent non-involvement of norepinephrine . Brain Res. 93:1975;441-454.
54. Sabeti J, Gerhardt GA, Zahniser NR (2000) Chloral hydrate, but not urethane, alters striatal dopamine transporter kinetics: electrochemical recordings in freely moving rats. Neurosci Abstr 1668.
55. Santiago M., Westerink B.H. Simultaneous recording of the release of nigral and striatal dopamine in the awake rat. Neurochem Int. 20:(suppl):1992;107S-110S.
56. Seeman P. Anti-schizophrenic drugs membrane receptor sites of action . Biochem Pharmacol. 26:1977;1741-1748.
57. Seeman P., Lee T., Chau-Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 261:1976;717-719.
58. Sharp T., Zetterstrom T., Ljungberg T., Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:1987;322-330.
59. Sokal R.R., Rohlf F.J. Biometry The principles and practice of statistics in biological research . 1995;W. H. Freeman, New York.
60. Starke K., Gothert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 69:1989;864-989.
61. Whishaw I.Q., Fiorino D., Mittleman G., Castaneda E. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats. Brain Res. 576:1992;1-11.
62. Wiedemann D.J., Garris P.A., Near J.A., Wightman R.M. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum. J Pharmacol Exp Ther. 261:1992;574-579.
63. Wiedemann D.J., Kawagoe K.T., Kennedy R.T., Ciolkowski E.L., Wightman R.M. Strategies for low detection limit measurements with cyclic voltammetry. Anal Chem. 63:1991;2965-2970.
64. Wightman R.M., Amatore C., Engstrom R.C., Hale P.D., Kristensen E.W., Kuhr W.G., May L.J. Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience. 25:1988;513-523.
65. Wightman R.M., Zimmerman J.B. Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res Brain Res Rev. 15:1990;135-144.
66. Wolf M.E., Roth R.H. Autoreceptor regulation of dopamine synthesis. Ann NY Acad Sci. 604:1990;323-343.
67. Wu Q., Reith M.E., Kuhar M.J., Carroll F.I., Garris P.A. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J Neurosci. 21:2001;6338-6347.
68. Yang H., Peters J.L., Michael A.C. Coupled effects of mass transfer and uptake kinetics on in vivo microdialysis of dopamine. J Neurochem. 71:1998;684-692.
69. Zetterstrom T., Sharp T., Ungerstedt U. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol. 106:1984;27-37.